Warning Letter Roundup: Four Facilities Cited for Procedural Failures

Drug GMP Report
A A
The FDA warned four drug manufacturers over a variety of procedural shortcomings, including ones for process control and sterility.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00